FDA and NIH Perspectives on Psychedelic Drug Development

The Food and Drug Administration (FDA) and the National Institutes of Health (NIH) communicated publicly about psychedelic drug development and current thinking around safety, therapeutic use, and research. The FDA Division of Psychiatry Products provided information in a workshop about how to design and efficiently study psychedelics for potential medical use.

Visions to Heed: Ketamine’s Breakout In Psychedelic Therapy

Psychedelic therapy holds a lot of promise, which medicine is right for you? Dr. Raquel Bennett describes her journey to find ketamine assisted psychotherapy and launch the first ketamine specific conference. She talks about different methods and approaches used in ketamine therapy. After struggling for over a decade with severe depression, Raquel Bennett turned to

How To Join a Psychedelic Clinical Trial

You could be eligible to participate in a psychedelic research trial. Studies of psychedelics are at various stages, enrolling both healthy volunteers and individuals with specific mental health conditions. We’ve compiled a list here of all the current or planned clinical trials on MDMA, psilocybin, LSD, Cannabis, and more. Regulatory approvals over the last few